BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 29557590)

  • 1. What are the remaining limitations of TAVI?
    De Biase C; Mastrokostopoulos A; Philippart R; Bonfils L; Berthoumieu P; Dumonteil N
    J Cardiovasc Surg (Torino); 2018 Jun; 59(3):373-380. PubMed ID: 29557590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of self-expandable vs. balloon-expandable TAVI for severe aortic stenosis.
    Tham JLM; Adams H; Paleri S; Wright C; Dimitriou J; Newcomb A; MacIsaac AI; Whitbourn RJ; Palmer SC
    Acta Cardiol; 2020 Jun; 75(3):218-225. PubMed ID: 30931804
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient selection for TAVI in 2016: should we break through the low-risk barrier?
    Abdelghani M; Serruys PW
    EuroIntervention; 2016 Sep; 12(Y):Y46-50. PubMed ID: 27640031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of transcatheter aortic valve implantation.
    Hamm CW; Arsalan M; Mack MJ
    Eur Heart J; 2016 Mar; 37(10):803-10. PubMed ID: 26578195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
    Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
    Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late degeneration of transcatheter aortic valves: pathogenesis and management.
    Barbanti M; Tamburino C
    EuroIntervention; 2016 Sep; 12(Y):Y33-6. PubMed ID: 27640028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
    Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open issues in transcatheter aortic valve implantation. Part 2: procedural issues and outcomes after transcatheter aortic valve implantation.
    Bax JJ; Delgado V; Bapat V; Baumgartner H; Collet JP; Erbel R; Hamm C; Kappetein AP; Leipsic J; Leon MB; MacCarthy P; Piazza N; Pibarot P; Roberts WC; Rodés-Cabau J; Serruys PW; Thomas M; Vahanian A; Webb J; Zamorano JL; Windecker S
    Eur Heart J; 2014 Oct; 35(38):2639-54. PubMed ID: 25062953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis.
    Ueshima D; Nai Fovino L; Mojoli M; Napodano M; Fraccaro C; Tarantini G
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):E159-E167. PubMed ID: 30019825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation.
    Toggweiler S; Nissen H; Mogensen B; Cuculi F; Fallesen C; Veien KT; Brinkert M; Kobza R; Rück A
    EuroIntervention; 2017 Dec; 13(11):1273-1280. PubMed ID: 28870877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAVR and Thrombosis.
    Trantalis G; Toutouzas K; Latsios G; Synetos A; Brili S; Logitsi D; Penesopoulou V; Tousoulis D
    JACC Cardiovasc Imaging; 2017 Jan; 10(1):86-87. PubMed ID: 28057223
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
    Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
    Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
    Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAPIEN S3 Leaflet Malfunction With Severe Intravalvular Aortic Insufficiency Immediately Post-Deployment.
    Singh GD; Southard JA; Smith TW; Boyd WD; Wong GB; Perry PA; Low RI
    JACC Cardiovasc Interv; 2017 Feb; 10(4):e31-e32. PubMed ID: 28231917
    [No Abstract]   [Full Text] [Related]  

  • 16. A feasibility study of transaxillary TAVI with the lotus valve.
    Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
    Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rottbauer W; Wöhrle J
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid-deployment or transcatheter aortic valves in intermediate-risk patients?
    Bruno P; Di Cesare A; Nesta M; Cammertoni F; Mazza A; Paraggio L; Rosenhek R; Burzotta F; Crea F; Trani C; Massetti M
    Asian Cardiovasc Thorac Ann; 2017 May; 25(4):264-270. PubMed ID: 28361580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term pacemaker dependency and impact of pacing on mortality following transcatheter aortic valve replacement with the LOTUS valve.
    Alasti M; Rashid H; Rangasamy K; Kotschet E; Adam D; Alison J; Gooley R; Zaman S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):777-782. PubMed ID: 29314625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sutureless versus Transfemoral Transcatheter Aortic Valve Implant: A Propensity Score Matching Study.
    Santarpino G; Vogt F; Pfeiffer S; Dell'Aquila AM; Jessl J; Cuomo F; von Wardenburg C; Fischlein T; Pauschinger M; Schwab J
    J Heart Valve Dis; 2017 May; 26(3):255-261. PubMed ID: 29092108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.